Cargando…
Clinicopathological characteristics of TERT promoter mutation and telomere length in hepatocellular carcinoma
Promoter mutations in telomerase reverse transcriptase (TERT) and telomere length have been studied in various tumors. In the present study, the frequency and clinical characteristics of TERT promoter mutation and telomere length were studied in hepatocellular carcinoma (HCC). TERT promoter mutation...
Autores principales: | Lee, Hye Won, Park, Tae In, Jang, Se Young, Park, Soo Young, Park, Won-Jin, Jung, Soo-Jung, Lee, Jae-Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5293416/ https://www.ncbi.nlm.nih.gov/pubmed/28151853 http://dx.doi.org/10.1097/MD.0000000000005766 |
Ejemplares similares
-
Long interspersed nuclear element-1 hypomethylation is associated with poor outcomes via the activation of ST18 in human hepatocellular carcinoma
por: Lee, Yu Rim, et al.
Publicado: (2021) -
Significance of TERT Genetic Alterations and Telomere Length in Hepatocellular Carcinoma
por: Jang, Jeong-Won, et al.
Publicado: (2021) -
Kallmann syndrome with a Tyr113His PROKR2 mutation
por: Ha, Jeong-Ha, et al.
Publicado: (2017) -
Genetic variations associated with telomere length affect the risk of gastric carcinoma
por: Lili, Ma, et al.
Publicado: (2020) -
RAS Mutations in AUS/FLUS Cytology: Does it Have an Additional Role in BRAF(V600E) Mutation-Negative Nodules?
por: Yoon, Jung Hyun, et al.
Publicado: (2015)